The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Westchase, Houston TX: FDA-Approved Relief for Treatment-Resistant Depression
Lead with what Spravato has achieved: More than 140,000 patients worldwide have been treated with Spravato — and Catalyst Health & Wellness brings that FDA-approved therapy to Westchase. Dr. Ho, board-certified anesthesiologist and former pediatrician, leads our REMS-certified program across three Houston locations, open Monday through Sunday, 5am to 9pm.
Spravato Treatment In The Memorial
Westchase moves fast. Over 1,500 businesses — from global energy companies like Chevron and Phillips 66 to technology firms and financial services — pack into 4.3 square miles of west Houston, making it one of the most commercially active and demographically diverse districts in the city. Residents and professionals here are accustomed to a dense, connected, fast-moving environment where things happen quickly and resources are accessible. That dynamic intensity is part of what makes Westchase distinctive.
It’s also what makes treatment-resistant depression so disruptive when it takes hold. Depression that hasn’t responded to antidepressants doesn’t pause for deadlines or adapt to demanding schedules. It doesn’t yield to willpower. And for the one in three depression patients who don’t achieve meaningful relief from monoamine-targeting medications — no matter how many are tried — the standard psychiatric toolkit simply doesn’t contain the answer. Catalyst Health & Wellness serves Westchase residents and workers — along with patients from Alief, Sharpstown, the International District, Briargrove, and greater west Houston — as a fully REMS-certified Spravato provider. Penn Medicine’s Perelman School of Medicine, which has been investigating ketamine-like treatments since 2012, confirms that intranasal esketamine “has proven effective as an adjunctive treatment for depression” and carries “a positive safety and tolerability profile.” That evidence, combined with Dr. Ho’s clinical expertise and Catalyst’s extended hours, means Westchase patients now have a treatment option that works at the pace this neighborhood demands.
What is Spravato Therapy?
Spravato (esketamine) arrived in psychiatry as something genuinely rare: a treatment that doesn’t just perform better than its predecessors — it operates on an entirely different principle. It earned FDA breakthrough therapy designation before receiving full approval in 2019, the first new antidepressant mechanism in over three decades. The FDA expanded that approval in 2020 to adults with major depressive disorder and active suicidal ideation or behaviors. In January 2025, the FDA approved Spravato as the world’s first standalone monotherapy for TRD — meaning qualifying patients can now use it as their only antidepressant, without a concurrently prescribed oral medication.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Westchase
Spravato holds FDA approval for two specific, well-established clinical indications — every qualifying Westchase patient receives a treatment with a comprehensively documented evidence record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every phase of the Spravato process at Catalyst has been built to reduce friction for Westchase patients with demanding schedules and full lives. Here's what to expect from first call through long-term care.
Step 1: Free Phone Consultation
Your first call costs nothing and commits you to nothing. A clinical team member will discuss your depression history, medication background, and what your daily life looks like now. You’ll get an honest assessment of whether Spravato fits your situation — and a direct answer if it doesn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles that entirely: benefit verification, documentation, prior auth submission, and insurer follow-up until approval is confirmed. You make the clinical decision; we handle the process.
Step 3: Before Your First Visit
Before your appointment, we’ll walk through everything: dietary guidelines, what to bring, how to arrange transportation, and timing notes for current medications. Nothing about your first session will be unclear before you arrive.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days isn’t permitted. Come comfortable and ready to rest.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room with a reclinable chair, soft adjustable lighting, warm blankets, and noise-cancelling headphones if you want them. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour window. Penn Medicine confirms these effects “attenuate with repeated doses,” so the experience generally becomes more comfortable as treatment continues.
Step 6: Recovery & Aftercare
After monitoring concludes, you’ll leave with your driver. Driving should wait until the morning following a full night’s sleep. Our team follows up between sessions to track your response and address anything before your next appointment.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based entirely on how you’re responding. Your progress shapes the schedule.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approval rests on two pivotal phase 3 randomized controlled trials, extended by a 2025 monotherapy study, and validated through nearly six years of post-approval safety data covering more than 140,000 patients in over 77 countries.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours — reflecting the neuroplasticity cascade initiated by NMDA receptor blockade, mTOR activation, and BDNF release. Penn Medicine’s team, which participated in clinical trials for esketamine from 2012, has noted firsthand that this mechanism produces “proven effective” antidepressant results in patients whose monoamine-targeting treatments have not.
The SUSTAIN-1 trial, published in JAMA Psychiatry, established durability. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued showed significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003) — confirming that maintenance treatment is a genuine clinical investment rather than a procedural formality.
Key research findings:
- Spravato’s S-enantiomer structure gives it approximately fourfold higher NMDA receptor affinity than R-ketamine, producing a more targeted and potent antidepressant effect at lower doses than racemic ketamine
- The ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid pharmacological option for that clinical population
- Side effects from intranasal esketamine “attenuate with repeated doses,” meaning the treatment experience typically becomes more comfortable as the therapeutic benefit builds
- The January 2025 FDA monotherapy approval means that qualifying Westchase patients can now use Spravato as their sole depression treatment without needing a concurrent oral antidepressant
Why Choose Catalyst Health & Wellness for Spravato Treatment in Westchase
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a certified healthcare setting under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Every session meets every federal safety standard — without shortcuts or exceptions.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s board certification in anesthesiology means deep expertise in esketamine pharmacology, precise clinical dosing, and the physician-level monitoring that administering an NMDA receptor antagonist in a supervised setting requires. His former career as a pediatrician shapes the clinic’s culture — patient-centered, unhurried, and genuinely attentive to how treatment feels from your perspective, not just how it appears on a chart. Westchase’s professional community deserves that level of clinical rigor combined with human attentiveness.
03
Insurance Navigation Support
Spravato stands apart from most innovative mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and for patients who’ve had prior authorization denied before, that process can feel like a barrier worth avoiding. Our team handles it entirely: benefit verification, prior auth submission, insurer follow-up, and appeals. We’ve navigated this across dozens of plans. Your energy belongs to healing, not paperwork.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your full treatment history, your current circumstances, your goals, and what you want back. Treatment plans are shaped by that picture and updated as your response evolves. What this means for you:
- Plans personalized to your specific history and present circumstances
- Ongoing adjustments based on real response data, not a fixed protocol
- Coordination with your existing psychiatrist or prescribing physician
- Long-term engagement extending well beyond the initial induction series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Westchase professionals managing demanding roles at global energy companies, technology firms, and financial services organizations — and the extended hours those environments often demand — carving out a standard-day clinical window is frequently impossible. Our 5am to 9pm hours, seven days a week at all three Houston locations, solve that. Pre-dawn appointments before the workday, evening sessions after it ends, weekend visits — all available. Treatment shouldn’t require taking time off from a life you’re trying to improve.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.
Getting Started with Spravato Treatment in Westchase
Westchase built its identity on connectivity and forward momentum — a district that positions itself explicitly to support the businesses and people within it. That same spirit applies to mental health care. If treatment-resistant depression has been the one place where forward momentum has stalled — where the available options have consistently come up short — Spravato is a clinically proven, FDA-approved path that moves differently from everything you’ve tried.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll walk through your history honestly, answer every question, and tell you clearly whether Spravato makes sense for your situation. No charge, no pressure, complete confidentiality.
Our Heights and Southwest locations are both accessible from Westchase via Westheimer and I-10. Three Houston locations, 5am to 9pm, seven days a week. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.